Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $61.01 million. The enterprise value is $17.88 million.

Market Cap	61.01M
Enterprise Value	17.88M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

OVID has 71.11 million shares outstanding. The number of shares has increased by 0.50% in one year.

Current Share Class	71.11M
Shares Outstanding	71.11M
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	35.77%
Float	59.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	70.86
Forward PS	136.18
PB Ratio	0.66
P/TBV Ratio	0.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.25.

Current Ratio	4.72
Quick Ratio	4.30
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.77% and return on invested capital (ROIC) is -27.32%.

Return on Equity (ROE)	-52.77%
Return on Assets (ROA)	-24.34%
Return on Invested Capital (ROIC)	-27.32%
Return on Capital Employed (ROCE)	-55.58%
Revenue Per Employee	$289,174
Profits Per Employee	-$1.64M
Employee Count	23
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.55% in the last 52 weeks. The beta is 0.21, so OVID's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+1.55%
50-Day Moving Average	0.43
200-Day Moving Average	0.62
Relative Strength Index (RSI)	79.83
Average Volume (20 Days)	2,779,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OVID had revenue of $6.65 million and -$37.72 million in losses. Loss per share was -$0.54.

Revenue	6.65M
Gross Profit	6.65M
Operating Income	-38.07M
Pretax Income	-50.68M
Net Income	-37.72M
EBITDA	-37.51M
EBIT	-38.07M
Loss Per Share	-$0.54

Full Income Statement

Balance Sheet

The company has $38.35 million in cash and $14.10 million in debt, giving a net cash position of $24.25 million or $0.34 per share.

Cash & Cash Equivalents	38.35M
Total Debt	14.10M
Net Cash	24.25M
Net Cash Per Share	$0.34
Equity (Book Value)	55.79M
Book Value Per Share	0.78
Working Capital	33.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.07 million and capital expenditures -$18,000, giving a free cash flow of -$49.60 million.

Operating Cash Flow	-40.07M
Capital Expenditures	-18,000
Free Cash Flow	-49.60M
FCF Per Share	-$0.70

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-572.46%
Pretax Margin	-574.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	-0.50%
Earnings Yield	-89.53%
FCF Yield	-117.73%

Analyst Forecast

The average price target for OVID is $3.13, which is 264.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.13
Price Target Difference	264.80%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	106.10%
EPS Growth Forecast (5Y)	29.14%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1